Rizatriptan
MAXALT, MAXALT-MLT
Serotonin-1b and Serotonin-1d Receptor Agonist
NADAC/unit
$0.4842
No Shortage
Tier 1: 110.9%
7 Manufacturers
18 ANDAs
vs. brand MAXALT: Generic saves up to 95% per unit
Market Intelligence
2025-07-23 Class II Recall: Ascend Laboratories, LLC
2025-07-23 Class II Recall: Ascend Laboratories, LLC
2024-06-12 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2024-06-12 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2024-06-12 Class II Recall: Glenmark Pharmaceuticals Inc., USA
Generic Manufacturers
ALKEM LABORATORIES LTDAUROBINDO PHARMA LTDCHARTWELL RX SCIENCES LLCCREEKWOOD PHARMACEUTICALS LLCGENSCO LABORATORIES LLC DBA GENSCO PHARMAMACLEODS PHARMACEUTICALS LTDORGANON LLCORGANON LLC A SUB OF ORGANON AND COPANACEA BIOTEC PHARMA LTDTEVA PHARMACEUTICALS USA
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.